AzTrials
AzTrials

Body SchemaENACTNCT05531162

Body-environment Relationship Related Modified Gravity

A study testing Cognition and emotional neuropsychologicl evaluations in people with Body Schema, run by University Hospital, Caen at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The overall objective of this study is to better understand the relationship between the body and its environment, including cognitive performance, following repeated changes in gravity, including microgravity (0G) and modified gravity (i.e., hypergravity (1.8G) and modified gravity (Martian gravity) Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Body Schema
What is being tested?
Cognition and emotional neuropsychologicl evaluations
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteFrance
Study dates
23 Oct 2022to 23 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Existence of an informed and written consent from the subject
  • Not pregnant
  • No anxiety disorder and/or depression
  • Not to have suffered a head injury
  • Have obtained a medical certificate of aptitude for parabolic flights
  • Be affiliated to the French Social Security, or have a European Health Insurance Card or equivalent

Who cannot join

  • Pregnant women, parturients and nursing mothers
  • Endocrine pathology (e.g., hyperthyroidism, diabetes)
  • High blood pressure
  • History of head trauma, mood or cardiovascular disorders, cognitive impairment
  • Recent illicit drug use
  • Alcohol dependence
Show all 13Show fewer
  • Neurological disease and/or history of neurological disease Psychiatric disease and/or history of psychiatric disease
  • Anti-inflammatory treatment
  • Psychotropic treatment
  • Treatments that interfere with heart rate (e.g., beta-blockers, calcium channel blockers, a1 receptor agonists)
  • Persons deprived of liberty, persons hospitalized without consent, persons admitted to a health or social institution for purposes other than research (L-1121-5 to L-1121-8-1)
  • Protected adults, adults unable to express their consent and not subject to a protective measure
  • Participation in other simultaneous trials if this or these protocols concern a pharmacological clinical trial

Trial locations and contacts

1 site in 1 country.

France1 site
  • Caen University Hospital

    Caen, 14033

Other trials in France

About this study

Official title: Repetitive Gravitationnal Changes on the Body-environment Relationship

The overall objective of this study is to better understand the relationship between the body and its environment, including cognitive performance, following repeated changes in gravity, including microgravity (0G) and modified gravity (i.e., hypergravity (1.8G) and modified gravity (Martian gravity)

Read the detailed description

On the eve of the next long voyages into space and the event of space tourism, it becomes more and more urgent to understand how to preserve the health of spacemen (i.e., by profession or by leisure). Extreme and unusual environments, and isolated and confined environments (EUE/ICE) are characterized by unique sensory stimulation. They are known to have negative effects on human psychology, cognitive abilities and physiology, threatening the outcome of space missions or travel. In addition, with the construction of the future Gateway base, the upcoming colonies to Mars and space tourism, travel from one point to another will be much more frequent. These raise new questions that will have to be addressed, whether it is the prolonged duration of a stay in a microgravity environment (i.e., absence of gravitational force between man and his support), in partial gravity and thus the issue of recovery from one trip to the next. These modifications of the environment imply the implementation of several adaptation processes to preserve the homeostatic capacity of the organism. This allows the organism to maintain a relatively stable internal state that persists despite external changes. Nevertheless, many questions remain unanswered. One such question is the impact of repeated changes in gravity during flight to the point of attachment (e.g., colony). The objective of the study is therefore to better understand the relationship between the body and its environment due to repeated changes in gravity, including microgravity.

Beyond that, these results will contribute to enrich the knowledge of this real human challenge that is the question of the adaptation of the human being to the constraints of space travel.

Conditions
Body Schema
Being tested
Cognition and emotional neuropsychologicl evaluations
Keywords
adaptation, cognition, extreme environment, confined environment, stress, performances, olfaction, somesthesia, space mission
Medical subject headings
Anosmia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognition and emotional neuropsychologicl evaluationsOther

    Cognitive ans sensory performances during repetitive micro and partial gravity exposure

Study groups in NCT05531162
Study groupRoleWhat they receive
Microgravity conditionOthera group of parabolic flyers exposed to micro and partial gravity
Receives: Other: Cognition and emotional neuropsychologicl evaluations

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Psychological data

    Freiburg Mindfulness Inventory questionnaire of 14 items (each item has a score from 1 to 4 i.e. minimal value 14 and maximal value 56, with a couple of reversed item to score)

    Measured: one hour before the flight

  2. Psychological data

    Freiburg Mindfulness Inventory questionnaire of 14 items (each item has a score from 1 to 4 i.e. minimal value 14 and maximal value 56, with a couple of reversed item to score)

    Measured: one hour after the flight

  3. stress

    Perceived Stress Scale questionnaire: 10 item-questionnaire to perceive stress (each item from 0 to 4: minimal value 0/no stress and maximal value 40 highest stress level)

    Measured: one hour before the flight

  4. stress

    Perceived Stress Scale questionnaire: 10 item-questionnaire to perceive stress (each item from 0 to 4: minimal value 0/no stress and maximal value 40 highest stress level)

    Measured: one hour after the flight

  5. Cognition

    Cognitive test battery questionnaire, 2D and 3D testing during one session: three scores ponderated (each with 6 plots represented with a spider graph measuring the surface from arbitrary unit)

    Measured: one hour before the flight

  6. Cognition

    Cognitive test battery questionnaire, 2D and 3D testing during one session: three scores ponderated (each with 6 plots represented with a spider graph measuring the surface from arbitrary unit)

    Measured: one hour after the flight

  7. Olfaction

    Olfactive discrimination test

    Measured: one hour before the flight

  8. Olfaction

    Olfactive discrimination test

    Measured: one hour after the flight

  9. Posture

    Ellipse of the center of gravity measurment

    Measured: one hour before the flight

  10. Posture

    Ellipse of the center of gravity measurment

    Measured: one hour after the flight

  11. Physiological data

    Heart Rate variability

    Measured: Continuous recording all along microgravity exposure up to 1hour after the end of the flight

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Sep 2022
  2. Study start23 Oct 2022
  3. Primary completion26 Apr 2023
  4. Study completion23 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Model description
a group of parabolic flyers with and without prior experience of microgravity
Masking
None (open label)
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05531162
Sponsor's protocol ID
2022-A01317-36
Acronym
ENACT
Status last verified
Jul 2025
First submitted
30 Aug 2022
Last updated
25 Jul 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Cognition and emotional neuropsychologicl evaluations in people with Body Schema, run by University Hospital, Caen at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Psychological data (time frame: one hour before the flight). The study lists 11 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Jul 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in